Search

Search Results

• Efficacy and Safety of Various Treatment Regimens for Primary CNS Lymphoma: Results of a Retrospective Study Based on the Data from Nine Saint Petersburg Medical Institutions

  Vladislav Vitalevich Markelov, Iu.S. Osipov, Yu.A. Alekseeva, S.V. Voloshin, N.A. Khasanova, S.A. Volchenkov, E.A. Ukrainchenko, E.S. Pavlyuchenko, A.Yu. Kuvshinov, Ju.N. Vinogradova, A.N. Gavrilenko, O.S. Uspenskaya, M.A. Ulyanova, V.G. Potapenko, I.A. Samorodova, V.V. Ryabchikova, I.S. Zyuzgin, A.M. Chekalov, M.V. Krivitskaya, Ya.B. Skiba, M.O. Popova, E.V. Kondakova, L.V. Stelmakh, L.V. Fedorova, K.V. Lepik, A.A. Gusak, V.V. Baykov, N.V. Medvedeva, G.N. Salogub, N.B. Mikhailova, A.D. Kulagin

  253-263

  01.07.2026

• Pola-R-CHP Regimen as First-Line Therapy for Diffuse Large B-Cell Lymphoma: A Retrospective Study of Real-World Clinical Practice

  Anastasiya Aleksandrovna Semenova, G.S. Tumyan, Yu.V. Ermakova, A.S. Chuprakova, A.P. Chernova, M.V. Frolova, N.B. Mikhailova, L.V. Fedorova, O.D. Serdyuk, S.V. Samarina, N.V. Nikolaeva, I.B. Lysenko, L.F. Mukharlyamova, G.N. Khusainova, N.V. Medvedeva, Ya.K. Mangasarova, A.Yu. Kuvshinov, D.V. Zaytsev, E.V. Karyagina, V.V. Denisova, T.I. Pospelova, I.N. Nechunaeva, K.S. Dedyukhina, N.G. Gabeeva, E.E. Zvonkov, A.D. Vorobev, O.S. Samoilova, I.V. Poddubnaya, Yu.V. Batukhtina, R.A. Zukov, E.N. Babich, T.N. Aleksandrova, I.S. Verkhoglyad, N.N. Glonina, I.Yu. Kudinova, E.A. Ukrainchenko, T.M. Sycheva, N.G. Ipatova, A.V. Proidakov, V.S. Morozov, G.Yu. Vyskub, V.V. Kobzev, E.V. Anikina, T.I. Ksenzova, Ya.V. Belenkaya, N.O. Zemlyakov

  241-252

  01.07.2026

• High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in the Third- and Subsequent-Line Therapy for Relapsed/Refractory Classical Hodgkin Lymphoma

  Vladislav Olegovich Sarzhevskiy, Yu.V. Protopopova, N.E. Mochkin, E.A. Demina, A.A. Mamedova, A.A. Samoylova, V.S. Bogatyrev, A.A. Rukavisyn, E.G. Smirnova, N.S. Shorokhov, A.E. Bannikova, V.Ya. Melnichenko

  310-319

  01.07.2026

• Effect of Bruton Tyrosine Kinase Inhibitors on T-Lymphocytes and Tumor Microenvironment Cells in B-Cell Lymphoproliferative Diseases

  Yuliya Sergeevna Efremova, T.V. Glazanova, N.A. Romanenko

  320-326

  01.07.2026

• Developing and Testing of an Original Molecular Panel for Evaluating the Efficacy of Acute Myeloid Leukemia Treatment and Early Diagnosis of Relapses by Quantitative Real-Time PCR

  Nikolai Nikolaevich Mamaev, Ya.V. Krylova, M.M. Kanunnikov, A.I. Shakirova, A.M. Sadykov, I.M. Barkhatov, B.I. Ayubova, T.L. Gindina, L.S. Zubarovskaya

  275-291

  01.07.2026

• Characteristics of Transfusion Replacement Therapy for Hematologic Patients in a Day-Care Unit

  Yuliya Vladimirovna Moor, N.V. Prosvirina, T.I. Pospelova

  302-309

  01.07.2026

• III Scientific Conference "Cellular Technologies in Oncohematology," V Scientific and Practical Conference "Modern Approaches to the Diagnosis and Treatment of Hematological Diseases." Abstracts of papers and reports.

  18.05.2026

• Treatment Efficacy for Pediatric Acute Myeloid Leukemias: Results of a Single-Center Trial

  E.V. Inyushkina, Sergei Olegovich Gunyakov, A.V. Bogucharskii, V.O. Stepanova

  142-151

  01.04.2026

• Primary Central Nervous System Lymphoma: A Literature Review, Diagnosis, Treatment, and Prognosis

  Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, O.P. Trofimova, G.D. Petrova, A.S. Subbotin, V.O. Shpirko, U.G. Koshkina, N.O. Zemlyakov, K.R. Gadzhibekov, G.S. Tumyan

  191-203

  01.04.2026

• Diagnosis and Treatment of Langerhans Cell Sarcoma: A Rare Case Report

  Timur Teimurazovich Valiev, A.M. Kovrigina, G.A. Radjabova

  204-210

  01.04.2026

• Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program

  Liudmila Valerevna Fedorova, N.B. Mikhailova, K.V. Lepik, A.M. Chekalov, O.G. Smykova, V.V. Markelov, G.S. Tumyan, A.A. Semenova, A.V. Arakelyan, L.S. Butaev, Iu.A. Oleinik, V.V. Ptushkin, Ya.K. Mangasarova, A.U. Magomedova, E.S. Gitelzon, N.G. Gabeeva, D.A. Koroleva, A.K. Smolianinova, E.E. Zvonkov, Iu.S. Osipov, N.V. Stepanova, T.V. Krinitsina, Yu.I. Podmankova, G.N. Khusainova, L.F. Mukharlyamova, O.R. Smirnova, I.V. Ishmatova, A.A. Zverkova, S.S. Elkhova, S.A. Volchenkov, I.S. Zyuzgin, D.D. Ivanova, E.A. Baryakh, E.N. Misyurina, P.A. Zeinalova, F.M. Abbasbeyli, O.L. Timofeeva, Yu.E. Ryabukhina, M.A. Ulyanova, V.V. Basmanova, T.N. Tsyganok, V.Yu. Kimaikina, S.V. Samarina, E.V. Zubkova, S.V. Ovanesyan, A.I. Iskhakova, A.Yu. Kuvshinov, A.A. Kuzyaeva, G.K. Isaeva, M.I. Andrievskikh, O.Yu. Arzhanukhina, T.V. Shelekhova, I.V. Morozova, P.V. Makarovskaya, O.S. Samoilova, I.V. Vasileva, A.Yu. Terekhova, N.A. Falaleeva, V.A. Shuvaev, S.V. Vlasova, V.A. Lapin, V.I. Bakhtina, A.D. Kulagin

  180-190

  01.04.2026

• NK-Cell Receptor Repertoire in Chronic Myeloid Leukemia

  Tamara Vangelevna Chitanava, R.A. Vlasik, L.O. Khordzhasov, A. Ataman, N.S. Luchkina, A.Yu. Aronov, I.D. Matvienko, N.T. Siordiya, O.V. Kulemina, N.S. Lazorko, E.I. Sbityakova, N.A. Shnalieva, E.N. Tochenaya, J.A. Alekseeva, P.A. Butylin, S.V. Smirnov, Yu. A. Zaritskii, Yu.P. Martinova, E.G. Lomaia

  152-161

  01.04.2026

• Anorectal Complications of Chemotherapy in Oncohematologic Patients

  Svetlana Vitalevna Shtyrkova, Z.T. Fidarova, A.I. Kashlakova, Yu.A. Chabaeva, S.M. Kulikov, K.I. Danishian, V.V. Troitskaya, E.N. Parovichnikova

  211-219

  01.04.2026

• Quality of Life and Symptom Profile in Polycythemia Vera Patients on Ruxolitinib Therapy in a Real-World Setting: Results of a Multi-Center Prospective Observational Study

  T.I. Ionova, Tatyana Pavlovna Nikitina, A.V. Proidakov, E.V. Lyurova, E.M. Volodicheva, L.A. Mkhitaryan, Yu.P. Martinova, T.V. Chitanava, N.B. Esefeva, M.O. Ivanova, T.I. Pospelova, A.S. Lyamkina, E.A. Knyazeva, E.G. Lomaia, N.S. Lazorko, K.P. Novoselov, D.A. Lipatova, N.M. Porfirieva, A.D. Kulagin

  14-26

  01.01.2026

• Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis

  A.G. Turkina, O. Yu. Vinogradova, E.G. Lomaia, B.A. Bakirov, N.M. Kalimulina, T.V. Shelekhova, I.L. Davydkin, T.I. Pospelova, O.A. Shukhov, E.Yu. Chelysheva, V.A. Shuvaev, S. Lavana, V. Khushoo, S. Apte, T.K. Dolai, R.K. Sahoo, Germes Grigorevich Chilov

  1-13

  01.01.2026

• Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

  Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin

  49-58

  01.01.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: A Literature Review and Our Own Experience

  Ulyana Gordeevna Koshkina, A.A. Semenova, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.I. Cherencova, S.F. Ramazanova, N.O. Zemlyakov, I.Z. Zavodnova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, G.S. Tumyan

  59-69

  01.01.2026

• The Optimal Background Cut-Off Threshold for Calculating Volumetric PET Biomarkers as Prognostic Factors in Classical Hodgkin Lymphoma

  Mariya Vasilevna Metelkina, I.P. Aslanidi, O.V. Mukhortova, D.M. Pursanova, V.A. Manukova, I.V. Shurupova, T.A. Trifonova, D.D. Zubkov, A.S. Rumyantsev

  39-48

  01.01.2026

• Characteristic Features of COVID-19 and Opportunities for Its Prevention in Multiple Myeloma Patients

  Darya Aleksandrovna Chebykina, I.I. Krobinets

  96-103

  01.01.2026

• The Prognostic Value of Positron Emission Tomography Findings in the Treatment of Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  A.S. Subbotin, Arman Vachakanovich Arakelyan, G.S. Tumyan, V.V. Solomyanyi, B.M. Khakulova, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, O.P. Trofimova, M.A. Senchenko, V.Yu. Kirsanov

  326-339

  01.10.2025

• Analysis of Plasma Circulating Cell-Free DNA in Acute Myeloid Leukemia Patients

  Elena Nikolaevna Voropaeva, M.V. Burundukova, I.A. Kuznetsova, P.S. Orlov, A.M. Nesterets, S.V. Minnikh, V.N. Maximov, T.I. Pospelova

  347-354

  01.10.2025

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• CAR-T Cell Therapy in Real-World Clinical Practice: An Experience of the NN Alexandrov National Cancer Centre of Belarus

  N.E. Konoplya, Volha Aleksandrovna Kalenik, P.D. Dziameshka, E.Yu. Zharkova, T.V. Savich, T.M. Doroshenko, I.N. Seviaryn, N.M. Bobrova, A.A. Beleevsky, E.Kh. Sarydze, S.L. Polyakov

  305-314

  01.10.2025

• Pathogenesis of Respiratory Distress in Acute Leukemia with Hyperleukocytosis

  Regina Ramilevna Tukhvatullina, N.V. Matinyan, T.T. Valiev, O.A. Ignatenko, N.V. Kokosadze, S.R. Varfolomeeva

  372-379

  01.10.2025

• New Prospects and Treatment Decisions for Oncohematological Patients (Resolution of Expert Panel)

  410-413

  01.10.2025

• DNA Methylation Genes in Multiple Myeloma: What We Already Know and How It Can Be Used?

  Daria Aleksandrovna Chebykina, E.V. Motyko, A.N. Kirienko, D.V. Kustova, O.B. Krysiuk, S.V. Sidorkevich, I.S. Martynkevich

  315-325

  01.10.2025

• Determination of the Minimal Residual Disease Threshold in Acute Myeloid Leukemia Treated with ‘ОМЛ-17’ and ‘mОМЛ-17’ Regimens

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, K.A. Nikiforova, Yu.O. Davydova, N.M. Kapranov, I.A. Lukianova, A.A. Ievleva, Yu.A. Chabaeva, Z.T. Fidarova, L. A. Kuzmina, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  340-346

  01.10.2025

• Treatment Opportunities in Epstein-Barr Virus-Associated Chronic Active Disease and Secondary Hemophagocytic Syndrome: A Case Series

  Vsevolod Gennadevich Potapenko, M.M. Antonov, D.D. Avdoshina, M.M. Aksenova, V.V. Baykov, M.B. Belogurova, I.A. Bekhtereva, L.V. Glyzhina, E.N. Dulaeva, Yu.V. Zabutova, V.E. Karev, N.A. Kotova, V.V. Kozyro, Yu.A. Krivolapov, T.G. Kulibaba, S.V. Lapin, E.E. Leenman, N.B. Mikhailova, S.I. Moiseev, A.A. Molchan, M.Yu. Pervakova, M.S. Petrova, O.P. Petrova, N.A. Potikhonova, V.V. Ryabchikova, D.R. Rakhimzyanova, I.A. Samorodova, A.V. Serkov, I.A. Skorokhod, K.V. Skoriukova, N.V. Skorobogatova, I.M. Slashcheva, E.A. Surkova, D.R. Smirnov, M.N. Smirnova, O.P. Mironova, O.V. Nebelitskaia, Yu.A. Nesterov, I.P. Fedunyak, A.N. Kholodnaia, N.Yu. Chernookaya, D.A. Chaginskaya, N.V. Medvedeva

  355-371

  01.10.2025

• Spontaneous Regression of Pulmonary Lymphomatoid Granulomatosis in a Patient with a Solid Tumor: A Case Report

  André Luiz Cicilini, P.P. Lago, F.L.M. Gallo, F.D. Costa, A.L.A. Dettino

  395-400

  01.10.2025

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• Which Calculations Are Required for Treating Patients with Multiple Myeloma?

  Aleksander Sergeevich Luchinin, A.A. Semenova

  218-226

  01.07.2025

• Sociomedical Profile and Quality of Life of Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Pathogenetic Therapy

  T.I. Ionova, A.D. Kulagin, E.A. Lukina, V.V. Ptushkin, E.G. Arshanskaya, T.N. Babaeva, B.A. Bakirov, S.V. Voloshin, G.P. Dimov, O.U. Klimova, E.Yu. Komarceva, O.L. Panteleeva, R.V. Ponomarev, T.I. Pospelova, S.V. Samarina, N.O. Saraeva, K.O. Farizova, M.N. Finyakina, A.A. Shutylev, D.A. Lipatova, N.M. Porfirieva, Tatyana Pavlovna Nikitina

  197-208

  01.07.2025

• Successful Treatment of Refractory Immune Thrombotic Thrombocytopenic Purpura with Daratumumab

  E.E. Klebanova, Gennadii Martinovich Galstyan, S.Yu. Mamleeva, D.K. Bessmertnyy, Z.T. Fidarova, E.N. Parovichnikova

  270-276

  01.07.2025

• The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  233-241

  01.07.2025

• Myeloid Sarcoma with Skin and Spinal Lesions and KRAS Gene Mutation, Complicated by Secondary Hemophagocytic Syndrome: A Case Report and Literature Review

  Tatyana Nikolaevna Tolstykh, O.L. Kochneva, E.N. Misyurina, E.A. Baryakh, M.A. Mingalimov, K.V. Yatskov, S.A. Kardovskaya, D.D. Ivanova, T.S. Chudnova, D.V. Lebedev, A.N. Titova, E.I. Zhelnova

  242-249

  01.07.2025

• A Rare Case of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

  Anastasiya Gennadevna Kolgotina, L.A. Kramynin, I.V. Ishmatova, L.V. Filatova, P.A. Sapronov, M.V. Grinkevich, A.L. Muravtseva, I.S. Zyuzgin

  277-285

  01.07.2025

• Epstein-Barr Virus-Associated Secondary Hemophagocytic Syndrome and Chronic Active Disease: A Literature Review

  Vsevolod Gennadevich Potapenko, M.M. Antonov

  286-292

  01.07.2025

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma and Classical Hodgkin Lymphoma: A Rare Case of Synchronous Lymphoid Tumors

  Leonid Aleksandrovich Kramynin, S.S. Elkhova, A.G. Kolgotina, L.V. Filatova, I.S. Zyuzgin, A.L. Muravtseva, R.V. Grozov

  209-217

  01.07.2025

• Comparative Efficacy Analysis of Mobilization and Collection of Autologous Hematopoietic Stem Cells in Patients with Lymphoproliferative Disorders and Multiple Sclerosis

  Oksana Vladimirovna Fedyk, V.O. Sarzhevskii, D.A. Fedorenko, V.Ya. Mel’nichenko, Yu.N. Dubinina, N.E. Mochkin, E.G. Smirnova, D.S. Kolesnikova, A.E. Bannikova

  51-58

  01.07.2025

• IV Scientific and Practical Conference "Modern Approaches to Diagnosis and Treatment of Hematological Diseases"; II Scientific Conference "Cellular Technologies in Oncohematology".. Abstracts of papers and reports.

  20.05.2025